phyllanthusmin C
isolated from Phyllanthus oligospermus;structure in first source
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Cheng, Rong-Rong:
1 article
(08/2014)
|
| 2. | Li, Sheng-Hong:
1 article
(08/2014)
|
| 3. | Wang, Dong:
1 article
(08/2014)
|
| 4. | Wang, Yan-Ming:
1 article
(08/2014)
|
| 5. | Wang, Yi-Fei:
1 article
(08/2014)
|
| 6. | Xu, Min:
1 article
(08/2014)
|
| 7. | Yang, Chong-Ren:
1 article
(08/2014)
|
| 8. | Zhang, Ying-Jun:
1 article
(08/2014)
|
| 9. | Zhao, Jian-Qiang:
1 article
(08/2014)
|
| 10. | Zhu, Hong-Tao:
1 article
(08/2014)
|
Related Diseases
| 1. | Esophageal Neoplasms (Esophageal Cancer)
08/01/2014
- " In addition, both of them and the known lignan glycoside, phyllanthusmin C, displayed moderate cytotoxicity against the ECA109 human esophagus cancer cell line, with the IC50 values of 11.5, 8.5, and 7.8 μM, respectively." 08/01/2014
- " In addition, both of them displayed moderate cytotoxicity against the ECA109 human esophagus cancer cell line, along with the known lignan glycoside, phyllanthusmin C, with the IC50 values of 11.5 (1), 8.5 (2), and 7.8 (phyllanthusmin C) μM, respectively. "
|
|
Related Drugs and Biologics